<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://bloodjournal.hematologylibrary.org">
<title>Blood CHEMOKINES, CYTOKINES, AND INTERLEUKINS</title>
<link>http://bloodjournal.hematologylibrary.org</link>
<description>Blood RSS feed -- recent CHEMOKINES, CYTOKINES, AND INTERLEUKINS articles</description>
<prism:eIssn>1528-0020</prism:eIssn>
<prism:publicationName>Blood</prism:publicationName>
<prism:issn>0006-4971</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://bloodjournal.hematologylibrary.org/cgi/content/short/112/12/4401?rss=1" />
  <rdf:li rdf:resource="http://bloodjournal.hematologylibrary.org/cgi/content/short/112/12/4411?rss=1" />
  <rdf:li rdf:resource="http://bloodjournal.hematologylibrary.org/cgi/content/short/112/12/4420?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://bloodjournal.hematologylibrary.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://bloodjournal.hematologylibrary.org/icons/banner/title.gif">
<title>Blood</title>
<url>http://bloodjournal.hematologylibrary.org/icons/banner/title.gif</url>
<link>http://bloodjournal.hematologylibrary.org</link>
</image>

<item rdf:about="http://bloodjournal.hematologylibrary.org/cgi/content/short/112/12/4401?rss=1">
<title><![CDATA[Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection]]></title>
<link>http://bloodjournal.hematologylibrary.org/cgi/content/short/112/12/4401?rss=1</link>
<description><![CDATA[
<p>HIV-1 infection is associated with B-cell abnormalities, such as hypergammaglobulinemia, poor immunization responses, and loss of serologic memory. To determine whether altered expression of chemokine receptors and their ligands may play a role in B-cell dysfunctions during HIV-1 infection, the expression of CXC chemokine receptor 4 (CXCR4), CXCR5, and CC chemokine receptor 7 (CCR7) and their respective ligands on CD19<sup>+</sup> B cells were examined in HIV-1&ndash;infected patients and controls. We report a decreased CXCR5 expression on B cells from patients (<I>P</I> &lt; .05), a phenomenon associated with a low CD4 T-cell count (&lt; 350 cells/&micro;L). Interestingly, an increased expression of CXC chemokine ligand 13 (CXCL13), the ligand for CXCR5, was found in peripheral B cells from HIV-1&ndash;infected patients. Moreover, on B-cell activation in vitro, CXCL13 was secreted in culture. CXCL13<sup>+</sup> B cells were also found in the lymph nodes of HIV-1&ndash;infected patients, but not in control tissue. B-cell migration toward CXCL13, CXCL12, and CC chemokine ligand 21 (CCL21), ligands for CXCR5, CXCR4, and CCR7 was also evaluated. In patients with a low CD4 T-cell count, migration toward all ligands was increased. Our findings indicate that altered expression of the chemokine receptor-ligand pair, CXCR5/CXCL13, may participate in the establishment of B-cell dysfunctions during HIV-1 infection.</p>
]]></description>
<dc:creator><![CDATA[Cagigi, A., Mowafi, F., Phuong Dang, L. V., Tenner-Racz, K., Atlas, A., Grutzmeier, S., Racz, P., Chiodi, F., Nilsson, A.]]></dc:creator>
<dc:date>2008-11-24</dc:date>
<dc:subject><![CDATA[Chemokines, Cytokines, and Interleukins]]></dc:subject>
<dc:identifier>info:doi/10.1182/blood-2008-02-140426</dc:identifier>
<dc:title><![CDATA[Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection]]></dc:title>
<dc:publisher>American Society of Hematology</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>112</prism:volume>
<prism:endingPage>4410</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>4401</prism:startingPage>
<prism:section>CHEMOKINES, CYTOKINES, AND INTERLEUKINS</prism:section>
</item>

<item rdf:about="http://bloodjournal.hematologylibrary.org/cgi/content/short/112/12/4411?rss=1">
<title><![CDATA[The IL-15 receptor {alpha} chain cytoplasmic domain is critical for normal IL-15R{alpha} function but is not required for trans-presentation]]></title>
<link>http://bloodjournal.hematologylibrary.org/cgi/content/short/112/12/4411?rss=1</link>
<description><![CDATA[
<p>IL-15 is critical for natural killer (NK)&ndash;cell development and function and for memory CD8<sup>+</sup> T-cell homeostasis. The IL-15 receptor consists of IL-15R, IL-2R&beta;, and the common cytokine receptor  chain (<SUB>c</SUB>). IL-15R is known to "<I>trans</I>-present" IL-15 to an IL-2R&beta;/<SUB>c</SUB> heterodimeric receptor on responding cells to initiate signaling. To investigate the importance of the IL-15R cytoplasmic domain, we generated a chimeric receptor consisting of the extracellular domain of IL-15R and intracellular domain of IL-2R (IL-15R<sup>ext</sup>/IL-2R<sup>int</sup>) and examined its function in 32D cells, in knock-in (KI) mice, and in adoptive-transfer experiments. The chimeric protein exhibited decreased cell-surface expression, and KI mice exhibited diminished NK, NKT, and CD8<sup>+</sup> T-cell development and defects in T-cell functional responses. However, 32D cells expressing the chimeric receptor had less IL-15&ndash;induced proliferation than wild-type (WT) transfectants with similar levels of IL-15R expression, indicating a signaling role for the IL-15R cytoplasmic domain beyond its effect on expression, and demonstrating that the IL-2R and IL-15R cytoplasmic domains are functionally distinct. Interestingly, adoptive-transfer experiments indicated that the chimeric IL-15R<sup>ext</sup>/IL-2R<sup>int</sup> receptor still supports <I>trans</I>-presentation. These experiments collectively indicate that IL-15R can act in <I>cis</I> in addition to acting in <I>trans</I> to present IL-15 to responding cells.</p>
]]></description>
<dc:creator><![CDATA[Wu, Z., Xue, H.-H., Bernard, J., Zeng, R., Issakov, D., Bollenbacher-Reilley, J., Belyakov, I. M., Oh, S., Berzofsky, J. A., Leonard, W. J.]]></dc:creator>
<dc:date>2008-11-24</dc:date>
<dc:subject><![CDATA[Chemokines, Cytokines, and Interleukins]]></dc:subject>
<dc:identifier>info:doi/10.1182/blood-2007-03-080697</dc:identifier>
<dc:title><![CDATA[The IL-15 receptor {alpha} chain cytoplasmic domain is critical for normal IL-15R{alpha} function but is not required for trans-presentation]]></dc:title>
<dc:publisher>American Society of Hematology</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>112</prism:volume>
<prism:endingPage>4419</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>4411</prism:startingPage>
<prism:section>CHEMOKINES, CYTOKINES, AND INTERLEUKINS</prism:section>
</item>

<item rdf:about="http://bloodjournal.hematologylibrary.org/cgi/content/short/112/12/4420?rss=1">
<title><![CDATA[Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation]]></title>
<link>http://bloodjournal.hematologylibrary.org/cgi/content/short/112/12/4420?rss=1</link>
<description><![CDATA[
<p>Initial molecular events leading to natural killer lymphocyte (NK) and dendritic cell (DC) interactions are largely unknown. Here, the role of CX3CL1 (fractalkine), a chemokine expressed on mature dendritic cells (mDCs) has been investigated. We show that CX3CL1 promotes NK activation by mDCs. After blocking of CX3CL1 by antibody, no activation occurred but major histocompatibility complex (MHC) class I neutralization restored DC-mediated NK activation, suggesting an interaction between CX3CL1 signaling and the functioning of inhibitory KIR. Then the YTS NK cell line, in which the inhibitory receptor KIR2DL1 had been introduced, was used. The presence of KIR2DL1 did not decrease YTS activation by HLA-Cw4 DC when CX3CL1 was functional. In contrast, CX3CL1 neutralization led to killer cell immunoglobulin-like receptor (KIR) phosphorylation and SHP-1 recruitment in YTS<sup>KIR2DL1</sup> cultured with HLA-Cw4 mDCs. Moreover, CX3CL1 neutralization promoted dispersion of lipid rafts and the formation of a multiprotein complex required for cytoskeletal rearrangements in YTS NK cells. These findings point to a pivotal role of CX3CL1 in the activation of resting NK cells by mature DCs.</p>
]]></description>
<dc:creator><![CDATA[Pallandre, J. R., Krzewski, K., Bedel, R., Ryffel, B., Caignard, A., Rohrlich, P. S., Pivot, X., Tiberghien, P., Zitvogel, L., Strominger, J. L., Borg, C.]]></dc:creator>
<dc:date>2008-11-24</dc:date>
<dc:subject><![CDATA[Brief Reports, Chemokines, Cytokines, and Interleukins]]></dc:subject>
<dc:identifier>info:doi/10.1182/blood-2007-12-126888</dc:identifier>
<dc:title><![CDATA[Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation]]></dc:title>
<dc:publisher>American Society of Hematology</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>112</prism:volume>
<prism:endingPage>4424</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>4420</prism:startingPage>
<prism:section>CHEMOKINES, CYTOKINES, AND INTERLEUKINS</prism:section>
</item>

</rdf:RDF>